1 |
Shehata AMF, Aldesoky AI, Gohar SF. Plasma fibrinogen level as possible prognostic biomarker in diffuse large B-cell lymphoma [J]. Hematology, 2019, 24(1): 103-107.
|
2 |
Grimm KE, O′Malley DP. Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues [J]. Ann Diagn Pathol, 2018, 38: 6-10.
|
3 |
Ramsay A, SmithW, Isaacson P. T-cell-rich B-cell lymphoma [J]. Am J Surg Pathol, 1988, 12: 433-443.
|
4 |
Lim MS, Beaty M, Sorbara L, et al. T-cell /histiocyte-rich large cell lymphoma.A heterogenerous entity with deriration from germinal center B cells [J]. Am J Surg Pathol, 2002, 26: 1458-1466.
|
5 |
Dogan A, Burke JS, GoteriG, et al. Micronodular T-cell/histiocyte rich large B-cell lymphoma of the spleen. Histology,immunophenotype, and differential diagnosis [J]. Am J Surg Pathol, 2003, 27: 903-911.
|
6 |
Fan Z, Natkunam Y, Bair E, et al. Characterization of variant patterns of nodular lymphocyte predom inant Hodgkin lymphoma with immunohistologic and clinical correlation [J]. Am J Surg Pathol, 2003, 27: 1346-1356.
|
7 |
Wei C, Wei C, Alhalabi O, et al. T-cell/histiocyte-rich large B-cell lymphoma in a child: A case report and review of literature [J]. World J Clin Cases, 2018, 6(6): 121-126.
|
8 |
Metts JL, Park SI, Briones MA, et al. Hemophagocytic lymphohistiocytosis secondary to T-Cell/Histiocyte-rich large B-cell lymphoma in an adolescent male [J]. Pediatr Dev Pathol, 2018, 21(1): 95-99.
|
9 |
Shafiq M, Karim F. A T-cell/histiocyte-rich large B-cell lymphoma involving only the bone marrow [J]. Blood Res, 2015, 50(4): 192.
|
10 |
Petrescu IO, Pleşea IE, Foarfa MC, et al. Rare thymic malignancy of B-cell origin-T-cell/histiocyte-rich large B-cell lymphoma [J]. Rom J Morphol Embryol, 2016, 57(3): 1075-1083.
|
11 |
Barut F, Kandemir NO, Gun BD, et al. T-cell/histiocyte-rich large B-cell lymphoma of stomach [J]. J Pak Med Assoc, 2016, 66(7): 905-907.
|
12 |
Advani P, Starr J, Swaika A. T-Cell/Histiocyte-rich large B-cell lymphoma presenting as a primary central nervous system lymphoma [J]. Rare Tumors, 2015, 7(4): 6084.
|
13 |
Zheng SM, Zhou DJ, Chen YH, et al. Pancreatic T/histiocyte-rich large B-cell lymphoma:A case report and review of literature [J]. World J Gastroenterol, 2017, 23(24): 4467-4472.
|
14 |
Kubota M, Taniguchi M, Tobisawa S, et al. T-Cell/Histiocyte-rich large B-Cell lymphoma presented as T-lymphoid hyperplasia involving the central nervous system [J]. Cureus, 2017, 9(3): e1119.
|
15 |
Boudova L, Torlakovic YE, De labie J, et al. Nodular lymphocy tepredom inant Hodgkin lymphoma with nodules resembling T-cell/histiocyte rich B-cell lymphoma:differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell /histiocy te-rich B-cell lymphoma [J]. Blood, 2003, 102: 3753-3758.
|
16 |
Hartmann S, Döring C, Vucic E, et al. Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma [J]. Br J Haematol, 2015, 169(3): 415-422.
|
17 |
Eyre TA, King AJ, Hatton C, et al. T-cell/histiocyte-rich large B-cell lymphoma--transformation of nodular lymphocyte predominant Hodgkin lymphoma in the bone marrow [J]. Eur J Haematol, 2014, 92(6): 550-551.
|
18 |
Rets AV, Gottesman SR. Nodular lymphocyte predominant Hodgkin lymphoma versus T-cell/Histiocyte-rich large B-cell lymphoma: A diagnostic challenge [J]. Case Rep Pathol, 2014: 956217.
|
19 |
Siricilla M, Irwin L, Ferber A. A Case of chemotherapy-refractory "THRLBCL like Transformation of NLPHL" successfully treated with lenalidomide [J]. Case Rep Oncol Med, 2018: 6137454.
|
20 |
Olivieri A, Sabattini E, Goteri G, et al. Fatal necrotizing angiotropic Epstein-Barr virus-negative large B-cell lymphoma: a case report with unusual clinicopathological features in-between lymphomatoid granulomatosis and T-cell/histiocyte-rich large B-cell lymphoma [J].Medicine (Baltimore), 2014, 93(29): e353.
|
21 |
Kunitomi A, Hasegawa Y, Asano N, et al. EBV-positive reactive hyperplasia progressed into EBV-positive diffuse large B-cell lymphoma of the elderly over a 6-year period [J]. Intern Med, 2018, 57(9): 1287-1290.
|
22 |
Hartmann S, Tousseyn T, Döring C, et al. Macrophages in T cell/histiocyte rich large B cell lymphoma strongly express metal-binding proteins and show a bi-activated phenotype [J]. Int J Cancer, 2013, 133(11): 2609-1618.
|